Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • neshua10 neshua10 Oct 4, 2013 10:11 AM Flag

    Don't have time at the moment but did you see what the new A- ole from the Street wrote about Celldex

    being broke, negative cash flow, in trouble; analysts are all wrong should be marked a SELL, etc. This person NEEDS to be fired and never write again. It is such utter BS!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This is pretty basic WS media nonsense. No doubt you could make the case that CLDX is over-priced based on recent quick moves up but real Q is are you looking at future growth/potential (and how far out are you looking) or trend lines based on tech. Tech this is over-priced but fundamentals are rock solid and risk/reward is there. IMHO

    • Did you really believe a big broker house read this #$%$ from the Street ???

      Sentiment: Strong Buy

    • What he said doesn't make sense. Their value is in pipeline and ability to raise cash such that they still own 100% of product. You could say a company that partners with Merck or similar has "deteriorating pipeline" when they go from 100% owned to 10% owned. Well, more important than the very small revenue from a product they only owned 1% of, is that they own 100% of the rest of their pipeline and have enough cash to stay that way.

    • The Street is talking out of both sides of it's mouth on CLDX. How can you treat clients that way????

    • It is about as poorly written as they get but could be adding to the decline. Issue though continues to be how do you value potential? There's just no fundamental level at where these become cheap based on any objective valuations so everyone's groping in the dark. Fear and greed rule. At present fear seems to have kicked in.

      • 1 Reply to islb3
      • Please send him an Email: NO BIO EXPERIENCE!

        David Aferiat

        Managing Partner at Trade-Ideas
        David brings more than 15 years of experience in trading, consulting, software, utilities, capital markets, and consumer product industries. Working with senior officers and key decision makers in the boardroom, finance, HR, marketing and trading functions, he has advised both public and privately held companies with revenues ranging from $20 million to $14 billion. Work at Trade-Ideas taps experience in business development, customer acquisition and retention, corporate strategy as well as energy trading and marketing. David holds dual Bachelor of Arts degrees in Economics and French from the University of Texas at Austin and a Masters of Business Administration degree from the Cox School of Business at Southern Methodist University.
        In seven years Trade Ideas has grown to over 50,000 accounts in 19 different countries. Hedge funds, Asset Managers, Institutions, Online Brokers, and direct access traders use the software as a premier idea generation, risk management, and decision support tool.

 
CLDX
15.36+0.25(+1.65%)Aug 28 4:00 PMEDT